Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer-Reference-Cited by-同舟云学术

Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer

Published:2018-10 Issue:5 Volume:1 Page:403-410
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Cantiello Francesco,Russo Giorgio I.,Vartolomei Mihai Dorin,Farhan Abdal Rahman Abu,Terracciano Daniela,Musi Gennaro,Lucarelli Giuseppe,Di Stasi Savino M.,Hurle Rodolfo,Serretta Vincenzo,Busetto Gian Maria,Scafuro Chiara,Perdonà Sisto,Borghesi Marco,Schiavina Riccardo,Cioffi Antonio,De Berardinis Ettore,Almeida Gilberto L.,Bove Pierluigi,Lima Estevao,Ucciero Giuseppe,Matei Deliu Victor,Crisan Nicolae,Verze Paolo,Battaglia Michele,Guazzoni Giorgio,Autorino Riccardo,Morgia Giuseppe,Damiano Rocco,de Cobelli Ottavio,Mirone Vincenzo,Shariat Shahrokh F.,Ferro Matteo

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference18 articles.

1. Tumor associated macrophages and neutrophils in cancer;Galdiero;Immunobiology,2013

2. Cancer-related inflammation;Mantovani;Nature,2008

3. The neutrophil-to-lymphocyte ratio as a prognostic factor for patients with urothelial carcinoma of the bladder following radical cystectomy: validation and meta-analysis;Lucca;Eur Urol Focus,2016

4. The role of inflammation in bladder cancer;Gakis;Adv Exp Med Biol,2014

5. The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients: a systematic review and meta-analysis;Tang;Int J Clin Oncol,2017

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibroblast Activation Protein-α and the Immune Landscape: Unraveling T1 Non–muscle-invasive Bladder Cancer Progression;European Urology Open Science;2024-08

2. Prognostic role of the neutrophil/lymphocyte ratio in high‐risk BCG‐naïve non‐muscle‐invasive bladder cancer treated with intravesical gemcitabine/docetaxel;BJU International;2024-07-31

3. Prognostic and clinicopathological significance of systemic immune-inflammation index in upper tract urothelial carcinoma: a meta-analysis of 3911 patients;Frontiers in Oncology;2024-06-14

4. The use of platelets as a clinical tool in oncology: opportunities and challenges;Cancer Letters;2024-06

5. Development and validation of a nomogram to predict lymph node metastasis in patients with progressive muscle-invasive bladder cancer;Frontiers in Oncology;2024-05-16